150 related articles for article (PubMed ID: 34369082)
1. DNM3OS regulates GAPDH expression and influences the molecular pathogenesis of Huntington's disease.
Dong X; Cong S
J Cell Mol Med; 2021 Sep; 25(18):9066-9071. PubMed ID: 34369082
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA DNM3OS/miR-204-5p/HIP1 axis modulates oral cancer cell viability and migration.
Fang X; Tang Z; Zhang H; Quan H
J Oral Pathol Med; 2020 Oct; 49(9):865-875. PubMed ID: 32463958
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DNM3OS regulates GREM2 via miR-127-5p to suppress early chondrogenic differentiation of rat mesenchymal stem cells under hypoxic conditions.
Zhou X; Xu W; Wang Y; Zhang H; Zhang L; Li C; Yao S; Huang Z; Huang L; Luo D
Cell Mol Biol Lett; 2021 May; 26(1):22. PubMed ID: 34049478
[TBL] [Abstract][Full Text] [Related]
5. DNM3OS Enhances the Apoptosis and Senescence of Spermatogonia Associated with Nonobstructive Azoospermia by Providing miR-214-5p and Decreasing E2F2 Expression.
Hua R; Chu Q; Guo F; Chen Q; Li M; Zhou X; Zhu Y
Anal Cell Pathol (Amst); 2023; 2023():1477658. PubMed ID: 38152068
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA H19 aggravates keloid progression by upregulating SMAD family member 5 expression via miR-196b-5p.
Li Z; Gong C; Wei H
Bioengineered; 2022 Jan; 13(1):1447-1458. PubMed ID: 34974806
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CASC9 attenuates lactate dehydrogenase-mediated oxidative stress and inflammation in spinal cord injury via sponging miR-383-5p.
Guan C; Wang Y
Inflammation; 2021 Jun; 44(3):923-933. PubMed ID: 33438067
[TBL] [Abstract][Full Text] [Related]
8. RP5-1120P11.3 promotes hepatocellular carcinoma development via the miR-196b-5p-WIPF2 axis.
Zhai H; Zhang X; Chen S; Fan M; Ma S; Sun X
Biochem Cell Biol; 2020 Apr; 98(2):238-248. PubMed ID: 31299165
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGFβ1 axes.
Wang R; Zhang M; Ou Z; He W; Chen L; Zhang J; He Y; Xu R; Jiang S; Qi L; Wang L
Aging (Albany NY); 2019 Nov; 11(21):9442-9460. PubMed ID: 31694982
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of long non-coding RNAs, microRNAs, and an accelerated epigenetic age in Huntington's disease.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Taheri M; Ebrahimzadeh K; Noroozi R
Front Aging Neurosci; 2022; 14():987174. PubMed ID: 36185471
[TBL] [Abstract][Full Text] [Related]
11. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DNM3OS promotes proliferation and inhibits apoptosis through modulating IGF1 expression by sponging MiR-126 in CHON-001 cells.
Ai D; Yu F
Diagn Pathol; 2019 Sep; 14(1):106. PubMed ID: 31526393
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease.
Wang ZM; Dong XY; Cong SY
J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838
[TBL] [Abstract][Full Text] [Related]
14. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E
Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of long non-coding RNAs and their mechanisms in Huntington's disease.
Tan X; Liu Y; Liu Y; Zhang T; Cong S
J Neurosci Res; 2021 Sep; 99(9):2074-2090. PubMed ID: 34031910
[TBL] [Abstract][Full Text] [Related]
16. Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's disease.
Hwang S; Disatnik MH; Mochly-Rosen D
EMBO Mol Med; 2015 Oct; 7(10):1307-26. PubMed ID: 26268247
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LINC00629 restrains the progression of gastric cancer by upregulating AQP4 through competitively binding to miR-196b-5p.
Li J; Wang L; He F; Li B; Han R
J Cell Physiol; 2020 Mar; 235(3):2973-2985. PubMed ID: 31674022
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
Chang KH; Wu YR; Chen CM
Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA NORAD protects against cerebral ischemia/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p/YWHAG.
Zhou X; Wang Z; Xu B; Ji N; Meng P; Gu L; Li Y
Bioengineered; 2021 Dec; 12(2):9174-9188. PubMed ID: 34709972
[TBL] [Abstract][Full Text] [Related]
20. The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.
Savary G; Dewaeles E; Diazzi S; Buscot M; Nottet N; Fassy J; Courcot E; Henaoui IS; Lemaire J; Martis N; Van der Hauwaert C; Pons N; Magnone V; Leroy S; Hofman V; Plantier L; Lebrigand K; Paquet A; Lino Cardenas CL; Vassaux G; Hofman P; Günther A; Crestani B; Wallaert B; Rezzonico R; Brousseau T; Glowacki F; Bellusci S; Perrais M; Broly F; Barbry P; Marquette CH; Cauffiez C; Mari B; Pottier N
Am J Respir Crit Care Med; 2019 Jul; 200(2):184-198. PubMed ID: 30964696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
